Cargando…

Structured pharmaceutical care improves the health-related quality of life of patients with asthma

BACKGROUND: Asthma as a chronic health condition can be controlled when in addition to clinical care, adequate education and support is provided to enhance self-management. Like many other chronic health conditions improved self-management positively impacts the health-related quality of life (HRQoL...

Descripción completa

Detalles Bibliográficos
Autores principales: Anum, Philip O., Anto, Berko P., Forson, Audrey G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297140/
https://www.ncbi.nlm.nih.gov/pubmed/28191318
http://dx.doi.org/10.1186/s40545-017-0097-7
_version_ 1782505685261484032
author Anum, Philip O.
Anto, Berko P.
Forson, Audrey G.
author_facet Anum, Philip O.
Anto, Berko P.
Forson, Audrey G.
author_sort Anum, Philip O.
collection PubMed
description BACKGROUND: Asthma as a chronic health condition can be controlled when in addition to clinical care, adequate education and support is provided to enhance self-management. Like many other chronic health conditions improved self-management positively impacts the health-related quality of life (HRQoL). It can therefore be said that a well-structured pharmaceutical care delivery that addresses the issues related to patient education and support towards self-management stands a good chance of positively impacting asthma control. This study evaluated the impact of a structured pharmaceutical care delivery on asthma control. METHODS: A prospective pre-/post- intervention study of a single cohort of 77 adult out-patients visiting specialist asthma clinics in Ghana were assessed for HRQoL and peak expiratory flow rates (PEFR) one month after pharmaceutical care intervention. Pharmaceutical care intervention covered education on the health condition, pharmacotherapy and self-management issues as well as correction of inhaler-use technique, where necessary and when to urgently seek medical care. The mean difference of the HRQoL and PEFR values were subjected to paired samples t-test analysis. RESULTS: Delivery of a structured pharmaceutical care led to a significant improvement in asthma specific quality of life and PEFR. The mean paired difference of the HRQoL for a cohort of patients with asthma post- pharmaceutical care intervention was 0.697(95% CI: 0.490 - 0.900) at t = 6.85 (p < 0.05). The mean paired difference for PEFR post intervention was 17.533 (95% CI: 2.876 - 32.190) at t = 2.384 (p = 0.02). CONCLUSION: This study identified important challenges with both the pharmacologic and the non-pharmacologic management of adult asthma patients. Inadequate inhaler-use skills, widespread occurrence of preventable adverse events and irregular use of preventer medicines were prevalent among patients. At one month after pharmaceutical care intervention, patients with asthma in a cohort follow-up study showed significant improvements with regard to asthma-specific quality of life, peak flow rates and knowledge TRIAL REGISTRATION: GHS-ERC: 08/9/11 of October 19, 2011.
format Online
Article
Text
id pubmed-5297140
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52971402017-02-10 Structured pharmaceutical care improves the health-related quality of life of patients with asthma Anum, Philip O. Anto, Berko P. Forson, Audrey G. J Pharm Policy Pract Research BACKGROUND: Asthma as a chronic health condition can be controlled when in addition to clinical care, adequate education and support is provided to enhance self-management. Like many other chronic health conditions improved self-management positively impacts the health-related quality of life (HRQoL). It can therefore be said that a well-structured pharmaceutical care delivery that addresses the issues related to patient education and support towards self-management stands a good chance of positively impacting asthma control. This study evaluated the impact of a structured pharmaceutical care delivery on asthma control. METHODS: A prospective pre-/post- intervention study of a single cohort of 77 adult out-patients visiting specialist asthma clinics in Ghana were assessed for HRQoL and peak expiratory flow rates (PEFR) one month after pharmaceutical care intervention. Pharmaceutical care intervention covered education on the health condition, pharmacotherapy and self-management issues as well as correction of inhaler-use technique, where necessary and when to urgently seek medical care. The mean difference of the HRQoL and PEFR values were subjected to paired samples t-test analysis. RESULTS: Delivery of a structured pharmaceutical care led to a significant improvement in asthma specific quality of life and PEFR. The mean paired difference of the HRQoL for a cohort of patients with asthma post- pharmaceutical care intervention was 0.697(95% CI: 0.490 - 0.900) at t = 6.85 (p < 0.05). The mean paired difference for PEFR post intervention was 17.533 (95% CI: 2.876 - 32.190) at t = 2.384 (p = 0.02). CONCLUSION: This study identified important challenges with both the pharmacologic and the non-pharmacologic management of adult asthma patients. Inadequate inhaler-use skills, widespread occurrence of preventable adverse events and irregular use of preventer medicines were prevalent among patients. At one month after pharmaceutical care intervention, patients with asthma in a cohort follow-up study showed significant improvements with regard to asthma-specific quality of life, peak flow rates and knowledge TRIAL REGISTRATION: GHS-ERC: 08/9/11 of October 19, 2011. BioMed Central 2017-02-07 /pmc/articles/PMC5297140/ /pubmed/28191318 http://dx.doi.org/10.1186/s40545-017-0097-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Anum, Philip O.
Anto, Berko P.
Forson, Audrey G.
Structured pharmaceutical care improves the health-related quality of life of patients with asthma
title Structured pharmaceutical care improves the health-related quality of life of patients with asthma
title_full Structured pharmaceutical care improves the health-related quality of life of patients with asthma
title_fullStr Structured pharmaceutical care improves the health-related quality of life of patients with asthma
title_full_unstemmed Structured pharmaceutical care improves the health-related quality of life of patients with asthma
title_short Structured pharmaceutical care improves the health-related quality of life of patients with asthma
title_sort structured pharmaceutical care improves the health-related quality of life of patients with asthma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297140/
https://www.ncbi.nlm.nih.gov/pubmed/28191318
http://dx.doi.org/10.1186/s40545-017-0097-7
work_keys_str_mv AT anumphilipo structuredpharmaceuticalcareimprovesthehealthrelatedqualityoflifeofpatientswithasthma
AT antoberkop structuredpharmaceuticalcareimprovesthehealthrelatedqualityoflifeofpatientswithasthma
AT forsonaudreyg structuredpharmaceuticalcareimprovesthehealthrelatedqualityoflifeofpatientswithasthma